Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Accumulated Expenses: 2010-2018

Historic Accumulated Expenses for Vanda Pharmaceuticals (VNDA) over the last 7 years, with Mar 2018 value amounting to $4.4 million.

  • Vanda Pharmaceuticals' Accumulated Expenses fell 85.47% to $4.4 million in Q1 2018 from the same period last year, while for Mar 2018 it was $4.4 million, marking a year-over-year decrease of 85.47%. This contributed to the annual value of $5.3 million for FY2017, which is 84.40% down from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Accumulated Expenses of $4.4 million as of Q1 2018, which was down 18.24% from $5.3 million recorded in Q4 2017.
  • In the past 5 years, Vanda Pharmaceuticals' Accumulated Expenses registered a high of $43.6 million during Q2 2015, and its lowest value of $602,000 during Q4 2014.
  • In the last 3 years, Vanda Pharmaceuticals' Accumulated Expenses had a median value of $31.3 million in 2017 and averaged $25.6 million.
  • Per our database at Business Quant, Vanda Pharmaceuticals' Accumulated Expenses crashed by 88.38% in 2014 and then surged by 5,805.32% in 2015.
  • Over the past 5 years, Vanda Pharmaceuticals' Accumulated Expenses (Quarterly) stood at $602,000 in 2014, then surged by 5,805.32% to $35.5 million in 2015, then declined by 4.01% to $34.1 million in 2016, then tumbled by 84.40% to $5.3 million in 2017, then tumbled by 85.47% to $4.4 million in 2018.
  • Its Accumulated Expenses was $4.4 million in Q1 2018, compared to $5.3 million in Q4 2017 and $25.6 million in Q3 2017.